We read with interest the article by Raggi et al, "Clinical, Operational, and Financial Impact of an Ultraviolet-C Terminal Disinfection Intervention at a Community Hospital." 1 Unfortunately, we believe that this article has methodological flaws, along with unreported data, which undermine the stated conclusions. It is a single-center, before-after study, in a 377-bed community hospital, with an illdefined primary outcome: incidence of multidrug-resistant (MDR) hospital-acquired infections (HAIs). The authors concluded that ultraviolet-C (UVC) terminal disinfection resulted in a statistically significantly reduced incidence of MDR HAIs, saving the hospital $1.2 million. 1 However, the cost of the UVC systems and their implementation was not provided, nor was it subtracted from the overall cost savings provided.The applied definition of HAIs was as follows: "(1) cultures collected after 48 hours of admission, (2) diagnosis at admission different from HAI diagnosis, and (3) colonization or infection contributing to increased length of hospital stay." 1 The culture sites included blood, body fluid, nares, sputum, urine, and wounds. It is unclear how it was determined whether HAI increased the length of stay. Single patients could have had multiple HAIs if multiple body sites were positive. How did the authors know which positive sample was responsible for an increased length of stay? Moreover, how did colonized nares increase the length of stay? Although positive blood cultures are most likely to indicate infection, culture-positive body fluids, sputum, or urine are less so, and positive nares almost never represent an infection. How can simple carriage events contribute to the incidence of HAI? This study did not evaluate HAI but rather colonization, which is an important difference and does not have the same implications.Furthermore, no information was provided on the MDR screening 0196-6553/Crown